` Comparison: GMAB, CYTH - Alpha Spread

GMAB
vs
CYTH

Over the past 12 months, GMAB has outperformed CYTH, delivering a return of -20% compared to the CYTH's 0% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
GMAB
CYTH
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

GMAB Intrinsic Value
1 612.26 DKK
Undervaluation 7%
Intrinsic Value
Price
CYTH Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Genmab A/S
CSE:GMAB
1 497.5 DKK
Cyclo Therapeutics Inc
NASDAQ:CYTH
9 900 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
GMAB, CYTH

GMAB
CYTH
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Genmab A/S
Revenue
Cyclo Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
GMAB, CYTH

GMAB
CYTH
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Genmab A/S
CSE:GMAB
Cyclo Therapeutics Inc
NASDAQ:CYTH
What is Free Cash Flow?

Gross Margin

GMAB
95.9%
CYTH
91.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

Operating Margin

GMAB
31.2%
CYTH
-2 834.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

Net Margin

GMAB
30%
CYTH
-2 848.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

FCF Margin

GMAB
-1.3%
CYTH
-2 586.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

ROE

GMAB
12.6%
CYTH
341.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

ROA

GMAB
11%
CYTH
-457.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

ROIC

GMAB
35.4%
CYTH
1 154.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

ROCE

GMAB
12.4%
CYTH
340.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Cyclo Therapeutics Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
GMAB, CYTH

Loading

Performance Gap
GMAB, CYTH

Loading
GMAB
CYTH
Difference
www.alphaspread.com

Performance By Year
GMAB, CYTH

Loading
GMAB
CYTH
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare GMAB to other stocks
Unlock Full Access to Alpha Spread
Create Free Account